Bal Pharma Enterprise Value (EV)

Bal Pharma Ltd Enterprise Value

The Bal Pharma Ltd Enterprise Value is a key financial metric used by investors to evaluate Bal Pharma Ltd's valuation, profitability, and overall financial performance. Tracking the Bal Pharma Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Bal Pharma Ltd (NSE: BALPHARMA, BSE: 524824) is currently trading at ₹64.87, with a market capitalization of ₹957.48M. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Bal Pharma Ltd Enterprise Value is essential for fundamental analysis.

Bal Pharma Ltd Enterprise Value Current Value

The current Bal Pharma Ltd Enterprise Value stands at 0.

The Bal Pharma Ltd Enterprise Value remains stable, indicating consistent financial performance.

Bal Pharma Ltd Enterprise Value Historical Trend

The Bal Pharma Ltd Enterprise Value has shown the following historical trend:

The decline in Bal Pharma Ltd Enterprise Value indicates improving financial efficiency or better earnings growth.

What Bal Pharma Ltd Enterprise Value Indicates for Investors

The Bal Pharma Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.

This ratio is an important metric used in fundamental analysis of Bal Pharma Ltd.

Bal Pharma Ltd Enterprise Value Analysis Summary

The Bal Pharma Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Bal Pharma Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Bal Pharma Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.